Peptide Therapy in Austin, TX Austin Plastic Surgeon Dr. Chuma FDA Action Update, January 2026: Approvals, Acceptance, and Clearance NeurologyLive Clinical Neurology News and Neurology Expert Insights The FDA just changed the game for peptides. April 2026 The FDA is reviewing Category 2 peptides for potential removal from restricted status. Full approval for some peptides may be GHK Cu Copper Peptide Research Compound Drexa Labs GHK Cu (20 mg) 5 vials customsupplements